Showing results (21-30 of 235) with videos related to

Sort By:
Pageof 24
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2011
A protein therapeutic modality founded on molecular regulationChapman M Wright, R Clay Wright, James R Eshleman, et al.
Cancer Research|February 24, 2001
Glycophosphatidylinositol-anchored protein deficiency as a marker of mutator phenotypes in cancerR Chen, J R Eshleman, R A Brodsky, et al.
Cancer Research|November 1, 1995
Both transforming growth factor-beta and substrate release are inducers of apoptosis in a human colon adenoma cell lineC Y Wang, J R Eshleman, J K Willson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Wild-type p53 protein potentiates cytotoxicity of therapeutic agents in human colon cancer cellsB Yang, J R Eshleman, N A Berger, et al.
American Journal of Clinical Pathology|May 3, 2025
Highly sensitive and specific markers for detection of mismatch repair deficiency by next-generation sequencingMing-Tseh Lin, Eric S Christenson, Aparna Pallavajjala, et al.
The Journal of Molecular Diagnostics : JMD|March 10, 2001
Use of single nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysisD H Oliver, R E Thompson, C A Griffin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2016
Microsatellite Instability as a Biomarker for PD-1 BlockadeJonathan C Dudley, Ming-Tseh Lin, Dung T Le, et al.
The Journal of Biological Chemistry|June 16, 1995
The hydroxy amino acid in an Asn-X-Ser/Thr sequon can influence N-linked core glycosylation efficiency and the level of expression of a cell surface glycoproteinL Kasturi, J R Eshleman, W H Wunner, et al.
Archives of Pathology & Laboratory Medicine|September 3, 2013
Fundamentals of pyrosequencingColleen T Harrington, Elaine I Lin, Matthew T Olson, et al.
The American Journal of Surgical Pathology|November 27, 2008
Benign nodal nevi frequently harbor the activating V600E BRAF mutationJanis M Taube, Shanaz Begum, Chanjuan Shi, et al.
Pageof 24